In recent years, the Indian medical community has placed greater emphasis on finding treatments for blood cancer. This heightened focus is driven by several key factors. The pivotal factor being the rising incidence of these diseases: India ranks third globally in reported blood cancer cases, with a new diagnosis every five minutes and around 70,000 annual deaths, shares Dr. Aman Priya Khanna, Bariatric, and Minimal Access Surgeon, New Delhi.

Secondly, leukaemia comprises over 50 per cent of cases, alongside rising lymphoma and myeloma instances. Consequently, there is a growing understanding of the various subtypes and complexities of blood cancers. Lastly, scientific researchers have made progress in unravelling the genetic and molecular mechanisms behind these diseases, allowing for more targeted and precise treatment approaches.